These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25770410)

  • 1. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
    Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
    JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
    Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
    JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
    Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
    J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
    Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices.
    Cowger JA; Castle L; Aaronson KD; Slaughter MS; Moainie S; Walsh M; Salerno C
    ASAIO J; 2016; 62(3):281-5. PubMed ID: 26955002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
    Cowger J; Sundareswaran K; Rogers JG; Park SJ; Pagani FD; Bhat G; Jaski B; Farrar DJ; Slaughter MS
    J Am Coll Cardiol; 2013 Jan; 61(3):313-21. PubMed ID: 23265328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.
    Critsinelis AC; Lamba HK; Nguyen MT; Conroy JR; Cheema FH; Civitello AB; Delgado RM; Nair AP; Oberton SB; Rosengart TK; Frazier OH; Morgan JA; Chatterjee S
    ASAIO J; 2020 May; 66(5):539-546. PubMed ID: 31335367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
    Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
    Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality.
    Loghmanpour NA; Kanwar MK; Druzdzel MJ; Benza RL; Murali S; Antaki JF
    ASAIO J; 2015; 61(3):313-23. PubMed ID: 25710772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience.
    Stein ML; Robbins R; Sabati AA; Reinhartz O; Chin C; Liu E; Bernstein D; Roth S; Wright G; Reitz B; Rosenthal D
    Circ Heart Fail; 2010 Nov; 3(6):682-8. PubMed ID: 20807863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.